China Grants First Approval of Homegrown COVID-19 Vaccine
A COVID-19 vaccine developed by a Chinese drugmaker is the first to be granted official approval by China’s government. The government’s National Medical Products Administration announced Thursday that it had given conditional approval to a vaccine developed by Beijing Biological Products Institute, a subsidiary of state-owned Sinopharm. The regulatory agency